249 related articles for article (PubMed ID: 23940256)
21. LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP.
Hochdörfer T; Tiedje C; Stumpo DJ; Blackshear PJ; Gaestel M; Huber M
Cell Signal; 2013 Jun; 25(6):1339-47. PubMed ID: 23499908
[TBL] [Abstract][Full Text] [Related]
22. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
23. IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence.
Datta S; Novotny M; Pavicic PG; Zhao C; Herjan T; Hartupee J; Hamilton T
J Immunol; 2010 Feb; 184(3):1484-91. PubMed ID: 20042592
[TBL] [Abstract][Full Text] [Related]
24. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
Sanduja S; Kaza V; Dixon DA
Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.
Sheibanie AF; Tadmori I; Jing H; Vassiliou E; Ganea D
FASEB J; 2004 Aug; 18(11):1318-20. PubMed ID: 15180965
[TBL] [Abstract][Full Text] [Related]
26. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
[TBL] [Abstract][Full Text] [Related]
28. Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation.
Gu L; Ning H; Qian X; Huang Q; Hou R; Almourani R; Fu M; Blackshear PJ; Liu J
J Immunol; 2013 Oct; 191(7):3922-30. PubMed ID: 23997224
[TBL] [Abstract][Full Text] [Related]
29. Life without TTP: apparent absence of an important anti-inflammatory protein in birds.
Lai WS; Stumpo DJ; Kennington EA; Burkholder AB; Ward JM; Fargo DL; Blackshear PJ
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R689-700. PubMed ID: 23904106
[TBL] [Abstract][Full Text] [Related]
30. Tristetraprolin expression by keratinocytes protects against skin carcinogenesis.
Assabban A; Dubois-Vedrenne I; Van Maele L; Salcedo R; Snyder BL; Zhou L; Azouz A; de Toeuf B; Lapouge G; La C; Melchior M; Nguyen M; Thomas S; Wu SF; Hu W; Kruys V; Blanpain C; Trinchieri G; Gueydan C; Blackshear PJ; Goriely S
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497366
[TBL] [Abstract][Full Text] [Related]
31. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
[TBL] [Abstract][Full Text] [Related]
32. A combination of hypoxia and lipopolysaccharide activates tristetraprolin to destabilize proinflammatory mRNAs such as tumor necrosis factor-alpha.
Werno C; Schmid T; Schnitzer SE; Peters K; Milke L; Brüne B
Am J Pathol; 2010 Sep; 177(3):1104-12. PubMed ID: 20639458
[TBL] [Abstract][Full Text] [Related]
33. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
Hau HH; Walsh RJ; Ogilvie RL; Williams DA; Reilly CS; Bohjanen PR
J Cell Biochem; 2007 Apr; 100(6):1477-92. PubMed ID: 17133347
[TBL] [Abstract][Full Text] [Related]
34. Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages.
Joe Y; Kim HJ; Kim S; Chung J; Ko MS; Lee WH; Chang KC; Park JW; Chung HT
J Biol Chem; 2011 Jul; 286(28):24735-42. PubMed ID: 21606497
[TBL] [Abstract][Full Text] [Related]
35. Multilevel regulation of HIF-1 signaling by TTP.
Fähling M; Persson AB; Klinger B; Benko E; Steege A; Kasim M; Patzak A; Persson PB; Wolf G; Blüthgen N; Mrowka R
Mol Biol Cell; 2012 Oct; 23(20):4129-41. PubMed ID: 22918951
[TBL] [Abstract][Full Text] [Related]
36. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation.
Schichl YM; Resch U; Hofer-Warbinek R; de Martin R
J Biol Chem; 2009 Oct; 284(43):29571-81. PubMed ID: 19654331
[TBL] [Abstract][Full Text] [Related]
37. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.
Chen F; Shyu AB; Shneider BL
Hepatology; 2011 Oct; 54(4):1371-8. PubMed ID: 21688286
[TBL] [Abstract][Full Text] [Related]
38. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.
Sun L; Stoecklin G; Van Way S; Hinkovska-Galcheva V; Guo RF; Anderson P; Shanley TP
J Biol Chem; 2007 Feb; 282(6):3766-77. PubMed ID: 17170118
[TBL] [Abstract][Full Text] [Related]
39. The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome.
Haneklaus M; O'Neil JD; Clark AR; Masters SL; O'Neill LAJ
J Biol Chem; 2017 Apr; 292(17):6869-6881. PubMed ID: 28302726
[TBL] [Abstract][Full Text] [Related]
40. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation.
Kratochvill F; Machacek C; Vogl C; Ebner F; Sedlyarov V; Gruber AR; Hartweger H; Vielnascher R; Karaghiosoff M; Rülicke T; Müller M; Hofacker I; Lang R; Kovarik P
Mol Syst Biol; 2011 Dec; 7():560. PubMed ID: 22186734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
